Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. - Wikidata - awgldk - TriplyDB

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

http://www.wikidata.org/entity/Q53250534

about

A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score Next-generation prognostic assessment for diffuse large B-cell lymphoma Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab Central nervous system prophylaxis in diffuse large B-cell lymphoma.Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034 Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP.Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma.Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy.Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.Proteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedside MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma Pathophysiology and molecular aspects of diffuse large B-cell lymphoma Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.A Study of the Newer Prognostic Markers in Diffuse Large B Cell Lymphomas.Diffuse large B cell lymphoma: from gene expression profiling to prediction of outcome Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.Primary sacral non-germinal center type diffuse large B-cell lymphoma with MYC translocation: a case report and a review of the literature.The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas.Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials Expression IRF/MUM1>25% Predictor to Three-year Survival of Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era.Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphoma.CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.

P2860

Q24653343-0FBC5D3E-08CB-4624-B7AA-AFBF5194E9BF Q26796428-184C8CF2-A724-4446-8757-AF4C28DD1D51 Q28256567-C5D84D3B-4347-4129-86CD-2E2FF0877E51 Q30251550-CCB2C7E7-262F-4325-8618-3900C0A20AE6 Q33551720-A0C260A1-5E77-4F36-B981-8AA1C3CF70A3 Q33561185-3BDA3827-2934-400F-A3E0-834DB2CB0C29 Q33700531-CC17A4C2-82C6-415B-AF00-7CAA0548950E Q33701858-55312BE4-4FCA-4BC4-8B77-58F34C73B46A Q34000188-1932DCC3-9DAE-4F0A-8DF4-31A52E2A78CB Q34302472-B110FE98-E615-484D-9B81-80233ECC425F Q34314938-575C5B49-3A5D-4654-8D6C-4A4957252A57 Q34390837-10D79D22-6314-4610-B5D4-DC97CE026A5B Q35384536-1481182E-0360-40FC-A305-0AE0A28CAD27 Q35590607-B8575B2D-B614-43DB-B3DC-A179A2DE308F Q35797583-F6E05345-0BB8-45F9-8A36-13022AD12761 Q35881693-0F85CB04-0D06-46FA-85A5-808ACE4E8D41 Q35915899-FEFA454D-C6BE-41E3-80EC-71B28D55069F Q35931598-65497D4F-B286-4D36-8AEF-A640EDFA5913 Q35989980-6D9F38AF-5559-4353-A7EE-FC357E1FF2A4 Q36210875-8CFC35C5-1FE7-417E-AF02-57B332084FE9 Q36534045-A36EE6E7-2728-45DA-AEFA-3D8D24571ECE Q36865089-5BF85AC0-EA56-4BAD-ACB2-BD1B6F30601D Q37037156-1E4FFCBA-B42F-4B37-9F25-BD9F46C0C355 Q37045955-40827D79-2906-40B7-A1D2-A37EB1011B60 Q37109671-95A88650-2D72-4CC6-A4E3-52819A6393AA Q37138035-69F2F0F6-DC7A-4801-AD6A-EB7433C439A7 Q37174123-24315462-3153-4E3B-96EB-D00A691468D9 Q37280910-DE0ACEE6-93EF-4FBD-BB80-C478B4BF9540 Q37301300-4A9F8A8B-8D4D-4294-94C0-67AB9673E107 Q37353917-99998934-F3EE-4E26-8514-4EDDC50B14B3 Q37406798-01143564-A3C3-4E4E-9B28-A12DCE1BB0C9 Q37470997-392A1CE8-A955-4A20-B330-151BB3DF2096 Q37635115-93F7DD49-B2A1-48B0-8128-DF804772A9EB Q37644833-39E6BFE8-5105-460D-8CB8-1FF171B750F8 Q37944927-133B3032-52C4-4E50-A305-30C690A427C1 Q38233772-EBD9648E-AF2E-4E4D-A0F5-B41D360A2FFF Q38459489-CF9ACE1C-9E79-4179-BD76-EF6DB1A6B7C2 Q39737169-E28EC1B5-4BB1-4AD3-9B99-5F62A2D0D6AD Q40491212-F8301633-7C52-41CC-A14E-AB0B45F0A02B Q40683450-CB89F5E5-BA23-40D4-AC87-3A764CCA7504

P2860

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

http://www.wikidata.org/entity/Q53250534

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Prognostic impact of germinal ...... diffuse large B-cell lymphoma.

@en

Prognostic impact of germinal ...... diffuse large B-cell lymphoma.

@nl

type

label

Prognostic impact of germinal ...... diffuse large B-cell lymphoma.

@en

Prognostic impact of germinal ...... diffuse large B-cell lymphoma.

@nl

prefLabel

Prognostic impact of germinal ...... diffuse large B-cell lymphoma.

@en

Prognostic impact of germinal ...... diffuse large B-cell lymphoma.

@nl

P1433

Q53250534-F1F81075-C817-49C4-A35B-3E5A5814068A

P1476

Q53250534-71A04FDE-4753-460C-8104-7D0891C6CFA8

P2093

Q53250534-1EB34110-181D-41D7-8D38-01CC7E5D7BFA

Q53250534-5B210578-540F-4CA1-BF35-29D25E1C80AB

Q53250534-77E4FC5E-AA4B-4985-9A25-12CE27295549

Q53250534-91E5CB73-C221-4C01-92A9-F3BAD4296786

Q53250534-E57467A8-FBCA-45A8-8EB8-A20B51211A51

Q53250534-E85095F9-102A-4EDA-A8F9-A45AF92F9FAC

P304

Q53250534-D6D4D8C7-3593-4474-B162-51F07BF0B596

P31

Q53250534-78B0743B-B16F-4D3B-949D-D5D3EE793F80

P356

Q53250534-02F33614-79DC-4D27-B6A0-33318A45618C

P407

Q53250534-654524B9-F626-49F8-A7ED-25366C2F8D98

P433

Q53250534-36CE2386-CB01-4BD1-85FB-7A180BBD5DD4

P478

Q53250534-DD4EEF9E-F3CC-434A-9DD6-AC2007879924

P50

Q53250534-EEF19051-5FF3-484A-A95F-A42478D12C5E

P577

Q53250534-B6157017-59A7-4F4A-BE93-02F48A26F103

P698

Q53250534-8257F532-FEBF-4B66-AAF5-60BAE2BAFCA8

P356

JCO.2006.05.5897

P1433

Journal of Clinical Oncology

P1476

Prognostic impact of germinal ...... diffuse large B-cell lymphoma.

@en

P2093

Bronno van der Holt

http://www.w3.org/2001/XMLSchema#string

Ed Schuuring

http://www.w3.org/2001/XMLSchema#string

Evert-Jan G Boerma

http://www.w3.org/2001/XMLSchema#string

Gustaaf W van Imhoff

http://www.w3.org/2001/XMLSchema#string

Leo F Verdonck

http://www.w3.org/2001/XMLSchema#string

Philip M Kluin

http://www.w3.org/2001/XMLSchema#string

P304

4135-4142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2006.05.5897

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Hanneke C Kluin-Nelemans

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16943530

http://www.w3.org/2001/XMLSchema#string